Web Results

Initial Regimen | Johns Hopkins HIV Guide


Oct 4, 2016 ... Gulick RM et al: Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Novel clinical trial designs for the development of new antiretroviral ...


Struble K, Murray J, Cheng B, Gegeny T, Miller V, Gulick R. Antiretroviral therapies ... Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, et al.

Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment ...


Aug 16, 2006 ... *Details reported in Gulick et al. .... Gulick RM, Mellors JW, Havlir D. et al. ... Triple -nucleoside regimens vs. efavirenz-containing regimens for the ..... at a reference laboratory at Johns Hopkins Hospital, Baltimore, Md. CD4 cell ...

The seductive allure is a reductive allure - School of Arts & Sciences


Taylor, & Hopkins, 2015), it is still unclear why this effect happens. One possibility is ... brain in plain language (e.g., ''brain scans”: Weisberg et al., 2015, ... Van Gulick, 2016). ...... adjacent pairs of fields (e.g., physics vs. chemistry, chemistry vs.

Download as a PDF - CiteSeerX


Jul 24, 2006 ... patients referred to the Johns Hopkins renal clinic from 1995 to 2004 was ..... Murphy RL, Gulick RM, DeGruttola V et al. Treatment with.

Ten Years of HAART: Foundation for the Future - Medscape Education


... MD, Johns Hopkins University School of Medicine, Baltimore, Maryland, presented a plenary lecture, "Ten Years of HAART: Principles for the Future. .... Head-to-head comparison of NNRTI- vs PI-based HAART: Results of ACTG .... Robbins GK, De Gruttola V, Shafer RW, et al. ... Gulick RM, Ribaudo HJ, Shikuma CM, et al.

Full Text (PDF)


Jun 9, 2009 ... Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21205. Contributed by .... ticipants (mean, 41.8 vs. 50.8 years) and had ..... In support of this view, Nettles et al. (32) ..... Gulick RM, et al. (1997) ...

New drugs for the treatment of HIV infection | SpringerLink


Cite this article as: Lee, K. & Gulick, R.M. Curr Infect Dis Rep (2001) 3: 193. doi: 10.1007/s11908-996-0058-9 ... Mewshaw J, Borroto-Esoda K, Wakefield D, et al.

Efficacy and safety of an anti-retroviral combination regimen ...


Dec 12, 2014 ... Data were analysed using SPSS v. .... of patients with HIV infection, John Hopkins Medicine Health Publishing Business ... 5; C Hicks, MS King, RM Gulick, et al. ... Efficacy and safety of tenofovir DF vs stavudine in combination ...

PDF(78K) - Wiley Online Library


1 Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2 The Aurum Institute ... time of detection of viraemia (Marconi et al. 2008;. Hoffmann et ... (Gulick et al. 1997 .... Johnston V, Fielding K, Charalambous S et al. (2012) Second ...

More Info

Zidovudine (AZT) | Johns Hopkins Antibiotic (ABX) Guide


May 28, 2014 ... Gulick RM et al: Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Dose-response Curve Slope Sets Class-Specific Limits on Inhibitory ...


Jun 15, 2008 ... However, clinical outcome may depend on whether 99% vs. 99.99% inhibition is achieved. ..... Gulick RM, et al. Treatment with indinavir ...

Antiretroviral therapy in the treatment of HIV-associated nephropathy


Jul 24, 2006 ... The Johns Hopkins Institutional Review Board approved the research protocol. HIVAN ..... Murphy RL, Gulick RM, DeGruttola V, et al. (1999) ...